Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AZN | AMGN | GILD | VRTX |
| Company | Clovis Oncology Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 71.35 | 293.86 | 109.67 | 467.69 |
| High | 0.0977 | 72.21 | 297.14 | 112.18 | 475.27 |
| Low | 0.0766 | 71.21 | 292.84 | 109.66 | 467.00 |
| Last | 0.0812 | 71.74 | 297.03 | 112.09 | 472.35 |
| Change | -0.0048 | +0.61 | +1.76 | +2.45 | +3.50 |
| % Change | -5.58% | +0.86% | +0.60% | +2.23% | +0.75% |
| Volume | 24,516,400 | 3,401,800 | 1,202,300 | 6,380,700 | 730,100 |
| 20-Day Average Volume | 9,433,500 | 4,086,440 | 2,723,195 | 8,214,670 | 1,256,995 |
| Previous Close | 0.0860 | 71.13 | 295.27 | 109.64 | 468.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 70.88 | 289.51 | 110.06 | 455.07 |
| 20-Day Raw Stochastic | 1.73% | 44.43% | 84.52% | 73.29% | 74.43% |
| 20-Day Relative Strength | 23.83% | 52.71% | 55.89% | 54.48% | 57.43% |
| Weighted Alpha | -91.19 | -6.62 | -7.00 | +48.80 | -1.54 |
| Today's Opinion | 100% Sell | 24% Buy | 16% Buy | 88% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 24% Buy | 8% Buy | 72% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 40% Sell | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +3.03% since 07/07/25 | +1.39% since 07/07/25 | +0.28% since 07/07/25 | +2.82% since 07/07/25 |
| Low | 0.0760 on 12/16/22 | 69.15 on 07/08/25 | 291.25 on 07/08/25 | 109.45 on 07/11/25 | 456.77 on 07/08/25 |
| High | 0.1439 on 12/14/22 | 72.46 on 07/10/25 | 302.38 on 07/10/25 | 114.87 on 07/10/25 | 484.56 on 07/10/25 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -3.60% since 06/13/25 | +0.61% since 06/13/25 | +1.92% since 06/13/25 | +3.71% since 06/13/25 |
| Low | 0.0760 on 12/16/22 | 69.15 on 07/08/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 436.80 on 06/20/25 |
| High | 0.3772 on 12/01/22 | 74.75 on 06/16/25 | 302.38 on 07/10/25 | 114.87 on 07/10/25 | 484.56 on 07/10/25 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | +5.48% since 04/14/25 | +1.06% since 04/14/25 | +5.25% since 04/14/25 | -4.74% since 04/14/25 |
| Low | 0.0760 on 12/16/22 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 1.3100 on 10/04/22 | 75.38 on 06/12/25 | 302.38 on 07/10/25 | 114.87 on 07/10/25 | 510.77 on 04/30/25 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | +9.74% since 01/14/25 | +11.21% since 01/14/25 | +23.18% since 01/14/25 | +14.74% since 01/14/25 |
| Low | 0.0760 on 12/16/22 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 90.82 on 01/16/25 | 415.13 on 01/15/25 |
| High | 3.2500 on 07/08/22 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 222,488,400 | 159,714,816 | 139,431,984 | 121,298,064 |
| Shares Outstanding, K | 144,955 | 3,101,316 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 148,760,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -264,520,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 30,660,000 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -56,010,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 0.24 | 0.37 | 0.49 | 0.29 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 11/09/22 | 07/29/25 | 08/05/25 | 08/14/25 | 08/04/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 06/13/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.47 | 14.22 | 14.17 | 0.00 |